<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药智网 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-21T20:11:30+08:00</updated>
  <subtitle>一个有态度、有深度、有温度的医药健康领域融媒体平台。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2020盘点：343个品种被承办，201个品种过评；复星、人福申报领衔；齐鲁、石药大赢家；豪森、恒瑞、科伦...</title>
    <updated>2020-12-21T17:23:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/Lsk7ZEyBc1bgBsnqTYmu8Q</id>
    <link href="https://mp.weixin.qq.com/s/Lsk7ZEyBc1bgBsnqTYmu8Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>临床I期产品引来艾伯维买下使用权，加科思今日上市，如何？</title>
    <updated>2020-12-21T17:23:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/WX20Ik9fIc7zE7W1DjntLQ</id>
    <link href="https://mp.weixin.qq.com/s/WX20Ik9fIc7zE7W1DjntLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>帕瑞昔布钠一路走好,一代大佬即将陨落</title>
    <updated>2020-12-21T17:23:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/P79sMbaiCf9J8MOcwpoS2Q</id>
    <link href="https://mp.weixin.qq.com/s/P79sMbaiCf9J8MOcwpoS2Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>29个大品种，带量采购正式执行（附名单）</title>
    <updated>2020-12-21T17:23:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/H23P-B2vmj0fpz7e_wqeGA</id>
    <link href="https://mp.weixin.qq.com/s/H23P-B2vmj0fpz7e_wqeGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【药咖君】2款国产1类新药获批上市！诺诚健华首款创新药即将获批，骨质疏松症迎来新药，恒瑞、海思科…</title>
    <updated>2020-12-19T23:25:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/jTboqc_IcJjOXexUm3I0Kg</id>
    <link href="https://mp.weixin.qq.com/s/jTboqc_IcJjOXexUm3I0Kg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【一周君】2020年医保谈判结束，引社会广泛关注；《自然》揭晓年度十大人物，国内两人上榜；恒瑞接连收获大好消息...</title>
    <updated>2020-12-18T21:54:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/bE7TvQWbvTEPDozddOFfGA</id>
    <link href="https://mp.weixin.qq.com/s/bE7TvQWbvTEPDozddOFfGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保目录谈判收官，显示需求侧“再出发”的特征？</title>
    <updated>2020-12-18T17:06:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/z6wzo7dSqglk0TtXziN9QA</id>
    <link href="https://mp.weixin.qq.com/s/z6wzo7dSqglk0TtXziN9QA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>他是海归博士，回国从0创业，缔造中国CDMO龙头企业！</title>
    <updated>2020-12-18T17:06:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/HT8oRpXiqd7fDgQ5PfbLxA</id>
    <link href="https://mp.weixin.qq.com/s/HT8oRpXiqd7fDgQ5PfbLxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>政策频发驱动互联网医疗加速发展：完善“互联网+”医疗在线支付工作，鼓励医疗机构提供在线服务</title>
    <updated>2020-12-18T17:06:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/XanFLqUWil1LthesVYW1yw</id>
    <link href="https://mp.weixin.qq.com/s/XanFLqUWil1LthesVYW1yw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>同写意论坛112期丨问道2021，药品创新投资何处去？</title>
    <updated>2020-12-18T17:06:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/NkxJ0VSdYv1aV9davJLz3A</id>
    <link href="https://mp.weixin.qq.com/s/NkxJ0VSdYv1aV9davJLz3A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国药企抢夺罕见病市场！亚盛医药斩获8项孤儿药资格，PD-1/L1单抗适应症成焦点，百济神州、君实…</title>
    <updated>2020-12-17T17:09:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/F9rFMx-39q6kBQ9PF1K7Fg</id>
    <link href="https://mp.weixin.qq.com/s/F9rFMx-39q6kBQ9PF1K7Fg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞股价再创历史新高，PD-1四个获批适应症进医保？</title>
    <updated>2020-12-17T17:09:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/cwSTrmLlKsHZQA_OojWHPA</id>
    <link href="https://mp.weixin.qq.com/s/cwSTrmLlKsHZQA_OojWHPA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠疫苗采购结果公布，200元/支，2家中标！</title>
    <updated>2020-12-17T17:09:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/oNZiBtTVU3525TBIyMoKvQ</id>
    <link href="https://mp.weixin.qq.com/s/oNZiBtTVU3525TBIyMoKvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判即将揭晓，化药多中药少。</title>
    <updated>2020-12-17T17:09:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/mquLf1fjLmsaoK_YhBo5dg</id>
    <link href="https://mp.weixin.qq.com/s/mquLf1fjLmsaoK_YhBo5dg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020下半年8大企业，上演年度“吃瓜大戏”</title>
    <updated>2020-12-16T17:15:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/bCVLw5Z43h3W4s03lgiZJw</id>
    <link href="https://mp.weixin.qq.com/s/bCVLw5Z43h3W4s03lgiZJw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>华润三九又出迷操作，一亿大手笔购入“赔钱货”</title>
    <updated>2020-12-16T17:15:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/lzB-nHGf6BxmGCMNSbsGsQ</id>
    <link href="https://mp.weixin.qq.com/s/lzB-nHGf6BxmGCMNSbsGsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药大省，对独家品种动手了！</title>
    <updated>2020-12-16T17:15:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/3-xN--vVu5vN-qFfimSZmw</id>
    <link href="https://mp.weixin.qq.com/s/3-xN--vVu5vN-qFfimSZmw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>变革之下，战略落地受阻，药企如何自我突破？</title>
    <updated>2020-12-15T17:11:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/XAuSO7Ql7GO5Kc3rO-5A9g</id>
    <link href="https://mp.weixin.qq.com/s/XAuSO7Ql7GO5Kc3rO-5A9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021预测！这两个版块将推动生物制药加速发展</title>
    <updated>2020-12-15T17:11:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/ZnhUnsexd_5njJFu9XKYeQ</id>
    <link href="https://mp.weixin.qq.com/s/ZnhUnsexd_5njJFu9XKYeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药智学院MDP精英训练营 | 医药数据检索与研发立项专题培训</title>
    <updated>2020-12-15T17:11:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/xt4cjPO0vioARDcqqlUegw</id>
    <link href="https://mp.weixin.qq.com/s/xt4cjPO0vioARDcqqlUegw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>